GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Average Recommendation of “Hold” from Brokerages

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has earned an average recommendation of “Hold” from the fourteen ratings firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $92.1667.

GEHC has been the subject of several analyst reports. Barclays lifted their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price target for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. BTIG Research reiterated a “buy” rating and set a $91.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, March 19th. Finally, Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $70.35 on Friday. GE HealthCare Technologies has a 12 month low of $57.65 and a 12 month high of $89.77. The firm’s 50 day moving average is $76.89 and its 200-day moving average is $78.03. The stock has a market capitalization of $32.10 billion, a PE ratio of 15.43, a P/E/G ratio of 1.55 and a beta of 1.17. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

Institutional Investors Weigh In On GE HealthCare Technologies

Several institutional investors and hedge funds have recently added to or reduced their stakes in GEHC. Laurel Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at $26,000. Optima Capital LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $27,000. Godfrey Financial Associates Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $27,000. Montag A & Associates Inc. boosted its stake in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC grew its position in GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.